Gene · 3416
Papers2,652
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,652
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of HHEX and SLC30A8 Gene Polymorphisms with Gestational Diabetes Mellitus Susceptibility: A Meta-analysis. | Biochem Genet | 2023 | 37103601 | PubTator, text mining | PubMed |
| Triglyceride-glucose index, Alzheimer's disease plasma biomarkers, and dementia in older adults: The MIND-China study. | Alzheimers Dement (Amst) | 2023 | 37101710 | PubTator, text mining | PubMed |
| CycloZ Improves Hyperglycemia and Lipid Metabolism by Modulating Lysine Acetylation in KK-Ay Mice. | Diabetes Metab J | 2023 | 37098411 | PubTator, text mining | PubMed |
| Oxidative stress: The nexus of obesity and cognitive dysfunction in diabetes. | Front Endocrinol (Lausanne) | 2023 | 37077347 | PubTator, text mining | PubMed |
| Development of a novel angiotensin converting enzyme 2 stimulator with broad implications in SARS-CoV2 and type 1 diabetes. | Res Sq | 2023 | 37066342 | PubTator, text mining | PubMed |
| An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha). | Front Pharmacol | 2023 | 37063285 | PubTator, text mining | PubMed |
| Identification of human phosphoglycerate mutase 1 (PGAM1) inhibitors using hybrid virtual screening approaches. | PeerJ | 2023 | 37051414 | PubTator, text mining | PubMed |
| Frontier Review of the Molecular Mechanisms and Current Approaches of Stem Cell-Derived Exosomes. | Cells | 2023 | 37048091 | PubTator, text mining | PubMed |
| The Labyrinthine Landscape of APP Processing: State of the Art and Possible Novel Soluble APP-Related Molecular Players in Traumatic Brain Injury and Neurodegeneration. | Int J Mol Sci | 2023 | 37047617 | PubTator, text mining | PubMed |
| Genetics and Epigenetics: Implications for the Life Course of Gestational Diabetes. | Int J Mol Sci | 2023 | 37047019 | PubTator, text mining | PubMed |
| Antibody-guided proteases enable selective and catalytic degradation of challenging therapeutic targets. | J Biol Chem | 2023 | 37031819 | PubTator, text mining | PubMed |
| Propensity-Matched Study of Early Cardiac Rehabilitation in Patients With Acute Decompensated Heart Failure. | Circ Heart Fail | 2023 | 37026462 | PubTator, text mining | PubMed |
| Cross-Sectional Gene-Smoking Interaction Analysis in Relation to Subclinical Atherosclerosis-Results From the IMPROVE Study. | Circ Genom Precis Med | 2023 | 37021583 | PubTator, text mining | PubMed |
| Rodent models of postherpetic neuralgia: How far have we reached? | Front Immunol | 2023 | 37020565 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Brain insulin signaling and cognition: Possible links. | EXCLI J | 2023 | 36998706 | PubTator, text mining | PubMed |
| The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer's Disease. | J Alzheimers Dis Rep | 2023 | 36994114 | PubTator, text mining | PubMed |
| Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma. | Epigenetics | 2023 | 36989117 | PubTator, text mining | PubMed |
| Intrathecal Pseudodelivery of Drugs in the Therapy of Neurodegenerative Diseases: Rationale, Basis and Potential Applications. | Pharmaceutics | 2023 | 36986629 | PubTator, text mining | PubMed |
| Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection. | Pharmaceutics | 2023 | 36986610 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3416/papers?page=12